Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Annick
Annick Arbellot De Vacqueur, Fontenay Les Briis FR
| Patent application number | Description | Published |
|---|---|---|
| 20080207720 | Novel Imidazolecarboxamide Derivatives as Fructose-1,6-Bisphosphatase Inhibitors, and Pharmaceutical Compositions Comprising Same - The invention relates to the compounds of the general formula (I): | 08-28-2008 |
| 20080312299 | Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them - Imidazole derivatives of formula (I) wherein R | 12-18-2008 |
| 20100286129 | NOVEL BENZIMIDAZOLEDIHYDROTHIADIAZINONE DERIVATIVES AS FRUCTOSE-1,6-BISPHOSPHATASE INHIBITORS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME - The present invention relates to novel benzimidazole-dihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, to processes for the preparation thereof and to the use thereof in therapy, especially for the treatment of diabetes. | 11-11-2010 |
Annick Bernalier, La Roche-Blanche FR
| Patent application number | Description | Published |
|---|---|---|
| 20100316617 | USE OF HYDROGENOTROPHIC ACETOGENIC STRAINS FOR PREVENTING OR TREATING DIGESTIVE DISORDERS - A method of modulating the microbial balance of the digestive ecosystem in a mammal comprising administering to a mammal in need thereof a composition comprising at least one nonpathogenic, hydrogenotrophic, acetogenic bacterial strain, along with a pharmaceutical and related methods, are described. | 12-16-2010 |
Annick De Poorter, Zele BE
| Patent application number | Description | Published |
|---|---|---|
| 20080200892 | Tampon - A tampon suitable for feminine hygiene and/or medical purposes having a longitudinal body provided with a dome-shaped insertion end and a withdrawal end, from which a withdrawal cord extends is disclosed. The tampon is made of compressed absorbent fibrous material and has an outer circumferential surface which is at least partially provided with longitudinal grooves that are separated from each other by longitudinal ribs. The path of the grooves and the ribs in the longitudinal direction of the tampon correspond to a continuous curved line that has only one point of inflection defining one convex part and one concave part, and that preferably does not show a maximum and/or a minimum. | 08-21-2008 |
| 20090024103 | TAMPON - A tampon suitable for feminine hygiene and/or medical purposes is disclosed having a longitudinal body provided with a dome-shaped insertion end and a withdrawal end, from which withdrawal end a withdrawal cord extends. The tampon has compressed absorbent fibrous material and has an outer circumferential surface which is at least partially provided with longitudinal grooves that are separated from each other by longitudinal ribs. The path of the grooves and ribs of the tampon in the longitudinal direction are inclined and correspond to a continuous curved line that has only one point of inflection defining one convex part and one concave part that preferably does not show a maximum or a minimum. | 01-22-2009 |
Annick Gargadennec, Montpellier FR
| Patent application number | Description | Published |
|---|---|---|
| 20110046077 | PROCESS FOR THE EXTRACTION OF MANGIFERIN AND ISOMANGIFERIN - The present invention relates to methods for extracting and isolating glycosyl xanthone derivatives, in particular mangiferin and isomangiferin, from plants of the Rubiaceae family, especially of the | 02-24-2011 |
Annick Gascons, Charenton FR
| Patent application number | Description | Published |
|---|---|---|
| 20090188429 | Ring for holding a lens for dip treatment thereof - The ring comprises a hoop ( | 07-30-2009 |
| 20110070364 | METHOD FOR HOLDING A LENS FOR DIP TREATMENT THEREOF - Method for dip treatment of an optical element, wherein the optical element is held, while it is being dipped, by a holding ring, the ring including a hoop for draining and encircling a peripheral edge of the optical element, thereby exerting continuous linear contact with the peripheral edge, the hoop forming an arc over more than 180° and being provided at each of its two ends with an outwardly-directed drip tab pointing away from the optical element. | 03-24-2011 |
Annick Goergler, Colmar FR
| Patent application number | Description | Published |
|---|---|---|
| 20090029962 | 2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS - The present invention relates to compounds of formula I | 01-29-2009 |
| 20100029589 | 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - The invention relates to compounds of formula I | 02-04-2010 |
| 20100041686 | 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - The invention relates to compounds of formula I | 02-18-2010 |
| 20110144333 | 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - The invention relates to compounds of formula I | 06-16-2011 |
Annick Harel-Bellan, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20080287385 | Inhibitor oligonucleotides and their use for specific repression of a gene - A double-strand oligonucleotide including two complementary oligonucleotide sequences forming a hybrid, each including at one of their 3′ or 5′ ends, one to five unpaired nucleotides forming single-strand ends extending beyond the hybrid, one of the oligonucleotide sequences being substantially complementary to a target sequence belonging to a DNA or RNA molecule to be specifically repressed, the target sequence belonging to a DNA or RNA molecule of a gene coding an angiogenic factor. | 11-20-2008 |
| 20090053718 | NOVEL OLIGONUCLEOTIDE COMPOSITIONS AND PROBE SEQUENCES USEFUL FOR DETECTION AND ANALYSIS OF microRNAs AND THEIR TARGET mRNAs - The invention relates to ribonucleic acids and oligonucleotide probes useful for detection and analysis of microRNAs and their target mRNAs, as well as small interfering RNAs (siRNAs). The invention furthermore relates to oligonucleotide probes for detection and analysis of other non-coding RNAs, mRNAs, mRNA splice variants, allelic variants of single transcripts, mutations, deletions, or duplications of particular exons in transcripts, e.g. alterations associated with human disease, such as cancer. | 02-26-2009 |
Annick Mercenier, Bussigny CH
| Patent application number | Description | Published |
|---|---|---|
| 20120021078 | NUTRITIONAL COMPOSITION COMPRISING AN APPLE EXTRACT AND REDUCING FOOD ALLERGY SYMPTOMS, ESPECIALLY IN CHILDREN - A complete nutritional composition comprising polyphenols is provided for reducing the symptoms of allergies originating from food allergens in young children or infants. Preferably the composition modulates the secondary prevention of allergies while not affecting significantly the primary prevention. The composition comprises an apple extract. | 01-26-2012 |
Annick Mercenier, Epalinges CH
| Patent application number | Description | Published |
|---|---|---|
| 20090274661 | USE OF BIFIDOBACTERIUM LONGUM FOR THE PREVENTION AND TREATMENT OF INFLAMMATION - The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of | 11-05-2009 |
| 20100322964 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 12-23-2010 |
| 20110021428 | PREVENTION OF ALLERGY AT WEANING - A nutritional composition comprising a partially hydrolysed milk protein having a degree of hydrolysis between 15 and 25% and 50 to 1000 nanograms of TGF-β per 100 ml of ready to consume composition and methods for the primary prevention of allergic reactions to newly introduced dietary protein at weaning and the prevention of development of atopic diseases in a young mammal at weaning comprising feeding to the young mammal a therapeutic amount of the composition are disclosed. | 01-27-2011 |
Annick Ocmant, Le Roeulx BE
| Patent application number | Description | Published |
|---|---|---|
| 20100129788 | METHOD FOR EVALUATING THE RESPONSE OF AN INDIVIDUAL TO A TREATMENT WITH A TYPE I INTERFERON (IFN) - A method for evaluating the in vivo presence of a factor that prevents the biological effect of a type I (IFN) in an individual that is under treatment with type I interferon is described. The in vivo presence of antibodies directed against a type I interferon (IFN) is evaluated in an individual that is under treatment with type I interferon. The method includes incubating a blood sample of the individual in vitro with a suitable amount of the type I interferon for a suitable period of time, and determining mRNA levels of a biological marker of IFN activity, preferably M×A, in the blood sample. The treatment may involve a treatment of multiple sclerosis, HCV or HBV using a type I interferon. | 05-27-2010 |
Annick Poliszczak, Rixensart BE
| Patent application number | Description | Published |
|---|---|---|
| 20090130145 | VACCINE - The invention provides an attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7. The invention particularly provides a rotavirus population designated as P43. The invention further provides a novel formulation for a rotavirus vaccine which is in the form of a quick dissolving tablet for immediate dissolution when placed on the tongue. | 05-21-2009 |
| 20090170066 | METHODS AND MATERIALS THEREFOR - The present invention relates to a method for detecting or detecting and identifying rotavirus in a biological sample. In particular, the invention relates to a detection method comprising contacting the nucleic acids from the sample or derived from the sample with at least one VP4 and/or VP7 universal probes in the context of a solid support and detecting any type-specific hybridisation. The invention further relates to a detection or detection followed by typing method comprising contacting the nucleic acids from the sample or derived from the sample with at least one P type-specific and G type-specific probes in the context of a solid support and detecting any type-specific hybridisation. The invention also relates to primers and probes used therein and to diagnostic kits. | 07-02-2009 |
Annick Pucci, Croissy-Sur-Seine FR
| Patent application number | Description | Published |
|---|---|---|
| 20080223753 | METHOD FOR DESULFURIZING HYDROCARBON FRACTIONS FROM STEAM CRACKING EFFLUENTS - The present invention relates to a method for treating a feed corresponding to a pyrolysis gasoline, comprising: | 09-18-2008 |
| 20090101545 | Method for Desulfurising Olefin Motor Gasoline - The invention concerns a process for producing gasoline with a low sulphur content and a controlled olefins content, comprising a step for oligomerizing an olefinic feed (step i), a step ii) consisting of mixing the branched olefinic gasoline produced in step i) with a gasoline rich in sulphur and olefins, a step iii) for hydrodesulphurization of said mixture, and separating the H | 04-23-2009 |
| 20110114538 | PROCESS FOR THE PRODUCTION OF HIGH-QUALITY KEROSENE AND DIESEL FUELS FOR THE COPRODUCTION OF HYDROGEN FROM SATURATED LIGHT CUTS - Process mainly for the production of high-quality kerosene and diesel fuels and for the coproduction of hydrogen from a so-called light naphtha cut to which any quantity of LPG cut can be added, employing the following successive stages: dehydrogenation of the paraffins, oligomerization of the olefins and hydrogenation of the oligomerized olefins, the process permitting the production of kerosene and diesel fuels meeting market specifications, or even improved relative to the latter. | 05-19-2011 |
Annick Sauger, Les Ulis FR
| Patent application number | Description | Published |
|---|---|---|
| 20110250702 | ISOLATED PEPTIDES OF RABBIT FACTOR VII - The present disclosure relates to peptides isolated from rabbit factor VII and to the use of thereof for the generation of antibodies specifically directed against the latter. The disclosure also relates to the use of antibodies directed against rabbit factor VII for the detection or purification of rabbit factor VII, specifically when said rabbit factor VII is in a biological sample which also contains human factor VII. | 10-13-2011 |
Annick Vandercammen, Rixensart BE
| Patent application number | Description | Published |
|---|---|---|
| 20110311577 | METHOD OF PRODUCING A VACCINE - The present invention relates to a method for purifying bacterial cytolysins such as pneumococcal pneumolysin. A single chromatography step produces excellent purification of the cytolysin by binding soluble aggregated cytolysin to a hydrophobic interaction chromatography material in the presence of detergent and high salt. | 12-22-2011 |
Annick Vanhulsel, Begijnendijk BE
| Patent application number | Description | Published |
|---|---|---|
| 20110223351 | LASER CLADDING OF A THERMOPLASTIC POWDER ON PLASTICS - A method applies a coating ( | 09-15-2011 |
Annick Vassout, Sierentz FR
| Patent application number | Description | Published |
|---|---|---|
| 20080306081 | Combinations of Nicotinic Acetylcholine Alpha 7 Receptor Antagonists - Combinations which comprise at least one nicotinic acetylcholine alpha 7 receptor agonist and at least one compound selected from the group consisting of (a) conventional antipsychotics (b) atypical antipsychotics (c) cognition, attention and/or memory enhancers (d) and to use of these combinations in the treatment of psychiatric disorders. | 12-11-2008 |
| 20100063029 | USE OF S-10-HYDROXY-10,11-DIHYDRO-CARBAMAZEPINE FOR THE TREATMENT OF ANXIETY AND BIPOLAR DISORDERS - The present invention relates to the use of a racemate of the compound of formula (I) consisting of at least 85% S-enantiomer and not more than 15% R-enantiomer or of pharmaceutically acceptable salts of said racemate or of the S-enantiomer of formula I or of pharmaceutically acceptable salts of said anantiomer for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or for the treatment of affective and attention disorders; pharmaceutical compositions for that purpose and packages comprising said pharmaceutical compositions together with instructions for the use of said compositions for the treatment of anxiety or other psychiatric disorders with underlying anxiety symptomatologies or of affective and attention disorders. | 03-11-2010 |
| 20100125063 | COMBINATIONS OF NICOTINIC ACETYLCHOLINE ALPHA 7 RECEPTOR AGONISTS - Combinations which comprise at least one nicotinic acetylcholine alpha 7 receptor agonist and at least one compound selected from the group consisting of (a) conventional antipsychotics (b) atypical antipsychotics (c) cognition, attention and/or memory enhancers (d) and to use of these combinations in the treatment of psychiatric disorders. | 05-20-2010 |